Practical recommendations for radium-223 treatment of metastatic castration-resistant prostate cancer

被引：0
|
作者：
Yong Du
Ignasi Carrio
Giuseppe De Vincentis
Stefano Fanti
Harun Ilhan
Caroline Mommsen
Egbert Nitzsche
Francis Sundram
Wouter Vogel
Wim Oyen
Val Lewington
机构：
[1] The Royal Marsden NHS Foundation Trust,Department of Nuclear Medicine & PET/CT
[2] Hospital Sant Pau,undefined
[3] Policlinico Umberto I University Hospital Rome,undefined
[4] University Hospital Bologna,undefined
[5] Ludwig-Maximilians-University Hospital,undefined
[6] Praxis für diagnostische und therapeutische Nuklearmedizin Berlin,undefined
[7] Canton Hospital Aarau,undefined
[8] University Hospital Southampton NHS Foundation Trust,undefined
[9] The Netherlands Cancer Institute,undefined
[10] The Institute of Cancer Research,undefined
[11] Guy’s and St Thomas’ NHS Foundation Trust,undefined
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2017年 / 44卷
关键词：
Bone metastases; Castration-resistant prostate cancer; Nuclear medicine; Radium dichloride; Ra-223; Targeted alpha therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1671 / 1678
页数：7
相关论文
共 50 条
  • [1] Practical recommendations for radium-223 treatment of metastatic castration-resistant prostate cancer
    Du, Yong
    Carrio, Ignasi
    De Vincentis, Giuseppe
    Fanti, Stefano
    Ilhan, Harun
    Mommsen, Caroline
    Nitzsche, Egbert
    Sundram, Francis
    Vogel, Wouter
    Oyen, Wim
    Lewington, Val
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (10) : 1671 - 1678
  • [2] Radium-223 In The Treatment Of Metastatic Castration-Resistant Prostate Cancer
    Vazzana, C.
    Morano, S.
    Di Lascio, A.
    Grana, C.
    Chinol, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S880 - S880
  • [3] Radium-223 for the treatment of castration-resistant prostate cancer
    El-Amm, Joelle
    Aragon-Ching, Jeanny B.
    [J]. ONCOTARGETS AND THERAPY, 2015, 8 : 1103 - 1109
  • [4] RADIUM-223: TREATING METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
    James, D.
    Hillery, R.
    Freeman, L.
    Kumari, A.
    Kearney, N.
    [J]. INTERNAL MEDICINE JOURNAL, 2016, 46 : 30 - 31
  • [5] Radium-223 for the treatment of metastatic castration-resistant prostate cancer: A window of opportunity
    Gomez-Veiga, F.
    Alvarez-Ossorio, J. L.
    Carballido-Rodriguez, J.
    Juarez-Soto, A.
    Rodriguez-Antolin, A.
    Cozar-Olmo, J. M.
    [J]. ACTAS UROLOGICAS ESPANOLAS, 2018, 42 (10): : 616 - 624
  • [6] Use of Radium-223 in Men With Metastatic Castration-Resistant Prostate Cancer
    Parker, Chris
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (11) : 723 - 725
  • [7] Radium-223 in the therapeutic sequence of metastatic castration-resistant prostate cancer
    Unda-Urzaiz, M.
    Sousa-Campo, R.
    Rodriguez-Antolin, A.
    Silva-Marins, C.
    Juarez-Soto, A.
    Minana-Lopez, B.
    Figueiredo-de Castro, A.
    Cozar-Olmos, J. M.
    [J]. ACTAS UROLOGICAS ESPANOLAS, 2018, 42 (04): : 227 - 237
  • [8] Efficacy of radium-223 dichloride in castration-resistant metastatic prostate cancer
    Sobrevilla Calvo, Pedro de Jesus
    [J]. GACETA MEXICANA DE ONCOLOGIA, 2016, 15 : 26 - 27
  • [9] The Contemporary Use of Radium-223 in Metastatic Castration-resistant Prostate Cancer
    Heinrich, Daniel
    Bektic, Jasmin
    Bergman, Andries M.
    Caffo, Orazio
    Cathomas, Richard
    Chi, Kim N.
    Daugaard, Gedske
    Keizman, Daniel
    Kindblom, Jon
    Kramer, Gero
    Olmos, David
    Omlin, Aurelius
    Sridhar, Srikala S.
    Tucci, Marcello
    van Oort, Inge
    Nilsson, Sten
    [J]. CLINICAL GENITOURINARY CANCER, 2018, 16 (01) : E223 - E231
  • [10] Optimal usage of radium-223 in metastatic castration-resistant prostate cancer
    Cha, Tai-Lung
    Wu, Tony Tong-Lin
    Vogelzang, Nicholas John
    Huang, Chao-Yuan
    Huang, Shu-Pin
    Lin, Chia-Chi
    Ou, Yen-Chuan
    Pang, See-Tong
    Shen, Daniel Heung-Yuan
    Wu, Wen-Jeng
    Chang, Wayne Yen-Hwa
    [J]. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2017, 116 (11) : 825 - 836
12345